Brookfield Real Assets Income
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RA research report →
Price Chart
About the company
Brookfield Real Assets Income Fund Inc. is a closed ended fixed income mutual fund launched and managed by Brookfield Investment Management Inc. The fund is co-managed by Schroder Investment Management North America Inc.
- CEO
- Gaal Surugeon
- IPO
- 2016
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on RA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $639.85M
- P/E
- 11.94
- PEG
- -0.39
- P/S
- 8.02
- P/B
- 0.82
- EV/EBITDA
- 13.46
- Div Yield
- 12.23%
- Gross Margin
- 84.06%
- Op Margin
- 82.48%
- Net Margin
- 67.39%
- ROE
- 6.82%
- ROIC
- 6.36%
Latest fiscal year · YoY change
- Revenue
- $77.57M+14.9%
- Gross Profit
- $64.74M+7.4%
- Op Income
- $74.85M
- Net Income
- $61.88M-3.9%
- EPS
- $1.12-5.1%
- OCF Growth
- +1405.9%
- FCF Growth
- +1405.9%
- 52W High
- $13.59
- 52W Low
- $11.41
- 50D MA
- $12.30
- 200D MA
- $12.77
- Beta
- 0.59
- RSI (14)
- 35
- Avg Volume
- 207.90K
No earnings-call transcripts are available for RA yet.
- Free Float
- 100.0%
- Shares Outstanding
- 55.25M
- Float Shares
- 55.25M
of shares held by institutions
114 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for RA, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 5.33M | ▲ 266.67K |
| Sit Investment Associates Inc | 3.06M | ▲ 207.28K |
| Wells Fargo & Company/Mn | 1.67M | ▲ 98.94K |
| Guggenheim Capital LLC | 1.06M | ▲ 71.68K |
| Penserra Capital Management LLC | 620.84K | ▲ 23.68K |
| Royal Bank Of Canada | 565.21K | ▼ 79.14K |
| Bank Of America Corp | 487.30K | ▲ 64.11K |
| Lpl Financial LLC | 395.19K | ▲ 96.57K |
| Thomas J. Herzfeld Advisors, Inc. | 369.08K | ▲ 28.44K |
| Envestnet Asset Management Inc | 292.22K | ▲ 24.69K |
| Raymond James Financial Inc | 279.03K | ▲ 49.04K |
| Cetera Investment Advisers | 278.10K | ▲ 20.16K |
Held by 16 ETFs
Biggest fund positions in RA by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | Goldman Heather S. | sell | 2,750 |
| Mar 31, 25 | O'Neal Riley | other | 0 |
| Mar 31, 25 | Horn Paula | other | 0 |
| Dec 12, 24 | MCFARLAND STUART A | sell | 1,860 |
| Nov 20, 24 | Schauffert-Tam Susan | other | 0 |
| Sep 17, 24 | Guichard Justin Charles | buy | 7,364 |
| Jan 1, 24 | Whelchel Betty | other | 0 |
| Dec 15, 23 | Goldman Heather S. | buy | 390 |
| Jan 8, 21 | Guichard Justin Charles | other | 0 |
| Sep 13, 23 | Janus Christopher | buy | 100 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our RA coverage
Recent articles, reports, and earnings notes.
No research on RA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RA report →Brookfield Real Assets Income Fund Inc. (NYSE:RA) Shareholders Set to Receive $0.12 Monthly Dividend
defenseworld.net · Oct 7
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
gurufocus.com · Sep 30
Brookfield Real Assets Income Fund (NYSE:RA) Stock Sale Disclosed by Rep. Kevin Hern
defenseworld.net · Sep 29
Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule
globenewswire.com · Sep 25
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
gurufocus.com · Sep 22
Short Interest in Brookfield Real Assets Income Fund Inc. (NYSE:RA) Drops By 36.8%
defenseworld.net · Aug 31
LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors
businesswire.com · Jul 27
RA: A Classic Fixed-Income CEF In 'Real Assets' Clothing
seekingalpha.com · Jul 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.